Despite this controversy, it was demonstrated that hormone-refractory tumors overexpress HOXB13 when compared to androgen-dependent carcinomas and its overexpression has been shown to promote prostate cancer invasion and metastasis [20,40]. This evidence concerns the gene HOXB13 and prostate carcinoma.